369 related articles for article (PubMed ID: 15850839)
1. Mesenchymal stem cells remain of host origin even a long time after allogeneic peripheral blood stem cell or bone marrow transplantation.
Rieger K; Marinets O; Fietz T; Körper S; Sommer D; Mücke C; Reufi B; Blau WI; Thiel E; Knauf WU
Exp Hematol; 2005 May; 33(5):605-11. PubMed ID: 15850839
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells obtained after bone marrow transplantation or peripheral blood stem cell transplantation originate from host tissue.
Dickhut A; Schwerdtfeger R; Kuklick L; Ritter M; Thiede C; Neubauer A; Brendel C
Ann Hematol; 2005 Oct; 84(11):722-7. PubMed ID: 16132912
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation.
Villaron EM; Almeida J; López-Holgado N; Alcoceba M; Sánchez-Abarca LI; Sanchez-Guijo FM; Alberca M; Pérez-Simon JA; San Miguel JF; Del Cañizo MC
Haematologica; 2004 Dec; 89(12):1421-7. PubMed ID: 15590390
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cells remain host-derived independent of the source of the stem-cell graft and conditioning regimen used.
Bartsch K; Al-Ali H; Reinhardt A; Franke C; Hudecek M; Kamprad M; Tschiedel S; Cross M; Niederwieser D; Gentilini C
Transplantation; 2009 Jan; 87(2):217-21. PubMed ID: 19155975
[TBL] [Abstract][Full Text] [Related]
5. Donor multipotent mesenchymal stromal cells may engraft in pediatric patients given either cord blood or bone marrow transplantation.
Pozzi S; Lisini D; Podestà M; Bernardo ME; Sessarego N; Piaggio G; Cometa A; Giorgiani G; Mina T; Buldini B; Maccario R; Frassoni F; Locatelli F
Exp Hematol; 2006 Jul; 34(7):934-42. PubMed ID: 16797421
[TBL] [Abstract][Full Text] [Related]
6. [Transplantation of mesenchymal derived stem cells followed by G-CSF injection can reconstitute hematopoiesis of lethally irradiated BALB/c mice].
Hu Y; Ma L; Ma GJ; Jiang XY; Zhao CH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Feb; 24(1):20-4. PubMed ID: 12905834
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH).
Koç ON; Day J; Nieder M; Gerson SL; Lazarus HM; Krivit W
Bone Marrow Transplant; 2002 Aug; 30(4):215-22. PubMed ID: 12203137
[TBL] [Abstract][Full Text] [Related]
8. Demonstration of donor origin of CD34+ HLA-DR- bone marrow cells after allogeneic peripheral blood transplantation with a long follow-up.
Briones J; Urbano-Ispizua A; Orfao A; Marín P; Sierra J; Rovira M; Carreras E; Rozman C; Montserrat E
Bone Marrow Transplant; 1998 Jan; 21(2):189-94. PubMed ID: 9489637
[TBL] [Abstract][Full Text] [Related]
9. Immune reconstitution after purified autologous and allogeneic blood stem cell transplantation compared with unmanipulated bone marrow transplantation in children.
Schwinger W; Weber-Mzell D; Zois B; Rojacher T; Benesch M; Lackner H; Dornbusch HJ; Sovinz P; Moser A; Lanzer G; Schauenstein K; Ofner P; Handgretinger R; Urban C
Br J Haematol; 2006 Oct; 135(1):76-84. PubMed ID: 16925797
[TBL] [Abstract][Full Text] [Related]
10. FISH analysis of native smears from bone marrow and blood for the monitoring of chimerism and clonal markers after stem cell transplantation in children.
Fuehrer M; Gerusel-Bleck M; Konstantopoulos N; Bender-Goetze C; Walther JU
Int J Mol Med; 2005 Feb; 15(2):291-7. PubMed ID: 15647846
[TBL] [Abstract][Full Text] [Related]
11. Constitution and telomere dynamics of bone marrow stromal cells in patients undergoing allogeneic bone marrow transplantation.
Lee JJ; Nam CE; Kook H; Maciejewski JP; Kim YK; Chung IJ; Park KS; Lee IK; Hwang TJ; Kim HJ
Bone Marrow Transplant; 2003 Nov; 32(9):947-52. PubMed ID: 14561997
[TBL] [Abstract][Full Text] [Related]
12. Disease- or therapy-related bone marrow damage cannot be overcome by changes in stem cell source or dose in allogeneic transplantation.
Novotny JR; Rosenthal C; Elmaagacli AH; Dürig J; Beelen DW; Dührsen U
Eur J Haematol; 2004 Jul; 73(1):1-9. PubMed ID: 15182331
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.
Tian Y; Deng YB; Huang YJ; Wang Y
Immunol Invest; 2008; 37(1):29-42. PubMed ID: 18214798
[TBL] [Abstract][Full Text] [Related]
14. CD34(+)-selected stem cell boost for delayed or insufficient engraftment after allogeneic stem cell transplantation.
Oyekunle A; Koehl U; Schieder H; Ayuk F; Renges H; Fehse N; Zabelina T; Fehse B; Klingebiel T; Sputtek A; Zander A; Kröger N
Cytotherapy; 2006; 8(4):375-80. PubMed ID: 16923613
[TBL] [Abstract][Full Text] [Related]
15. Liver chimerism after allogeneic blood stem cell transplantation.
ten Hove WR; Verspaget HW; Barge R; Lamers CB; van Hoek B
Transplant Proc; 2007; 39(1):231-6. PubMed ID: 17275511
[TBL] [Abstract][Full Text] [Related]
16. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
[TBL] [Abstract][Full Text] [Related]
17. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
Kasow KA; Sims-Poston L; Eldridge P; Hale GA
Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
[TBL] [Abstract][Full Text] [Related]
18. Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults.
Gonzalo-Daganzo R; Regidor C; Martín-Donaire T; Rico MA; Bautista G; Krsnik I; Forés R; Ojeda E; Sanjuán I; García-Marco JA; Navarro B; Gil S; Sánchez R; Panadero N; Gutiérrez Y; García-Berciano M; Pérez N; Millán I; Cabrera R; Fernández MN
Cytotherapy; 2009; 11(3):278-88. PubMed ID: 19308773
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of chimerism after allogeneic stem cell transplantation by real-time polymerase chain reaction with single nucleotide polymorphisms, standard tandem repeats, and Y-chromosome-specific sequences.
Koldehoff M; Steckel NK; Hlinka M; Beelen DW; Elmaagacli AH
Am J Hematol; 2006 Oct; 81(10):735-46. PubMed ID: 16838323
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia.
Ishikane S; Ohnishi S; Yamahara K; Sada M; Harada K; Mishima K; Iwasaki K; Fujiwara M; Kitamura S; Nagaya N; Ikeda T
Stem Cells; 2008 Oct; 26(10):2625-33. PubMed ID: 18669910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]